o-Nitroanilines as major metabolic products of anti-Trypanosoma cruzi 5-phenylethenylbenzofuroxans in microsomal and cytosolic fractions of rat hepatocytes and in whole parasitic cells

References

• Aguirre G, Boiani L, Boiani M, Cerecetto H, Di Maio R, González M, Porcal W, Denicola A, Piro OE, Castellano EE, Sant’Anna CMR, Barreiro EJ.2005b. New potent 5-substituted benzofuroxans as inhibitors of Trypanosoma cruzi growth. Quantitative structure–activity relationship studies. Bioorgan Med Chem 13:6336–6346.
   PubMedGoogle Scholar
• Aguirre G, Boiani L, Cerecetto H, Di Maio R, González M, Porcal W, Thomson L, Tórtora V, Denicola A, Möller M.2005a. Benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as potential antitrypanosomal drugs. Part III. Substituents-clustering methodology in the search of new active compounds. Bioorgan Med Chem 13:6324–6335.
   PubMedGoogle Scholar
• Aguirre G, Cerecetto H, Di Maio R, González M, Porcal W, Seoane G, Denicola A, Ortega MA, Aldana I, Monge-Vega A. (2002). Benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as potential antitrypanosomal drugs. Structure–activity relationships. Part II. Archiv Pharmazie 335:15–21.
   PubMedGoogle Scholar
• Alexanian V, Haddadin MJ, Issidorides CH, Nazer MZ. (1981). A note on the oxidative capacity of benzofurazan oxide. Heterocycles 16:391–398.
   Google Scholar
• Boiani L, Davies C, Arredondo C, Porcal W, Merlino A, Gerpe A, Boiani M, Pacheco JP, Basombrío MA, Cerecetto H, González M. (2008). In vivo studies of 5-arylethenylbenzofuroxans in acute murine models of Chagas disease. Eur J Med Che 43:2229–2237.
   PubMedGoogle Scholar
• Cerecetto H, Di Maio R, González M, Risso M, Saenz P, Seoane G, Denicola A, Peluffo G, Quijano C, Olea-Azar C. (1999). 1,2,5-Oxadiazole N-oxide derivatives and related compounds as potential antitrypanosomal drugs. Structure–activity relationships. J Med Chem 42:1941–1950.
   PubMed Web of Science ®Google Scholar
• Cerecetto H, González M. (2002). Chemotherapy of Chagas disease: status and new developments. Curr Topic Med Chem 2:1185–1211.
   Google Scholar
• De Mecca MM, Fanelli SL, Bartel LC, de Castro CR, Díaz EG, Castro JA. (2007). Nifurtimox nitroreductase activity in different cellular fractions from male rat pancreas. Biochemical and ultrastructural alterations. Life Sci 81:144–152.
   PubMedGoogle Scholar
• Denicola A, Rubbo H, Rodriguez D, Radi R. (1993). Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi. Arch Biochem Biophys 304:279–286.
   PubMed Web of Science ®Google Scholar
• Gerpe A, Merlino A, Boiani M, Porcal W, Fagiolino P, González M, Cerecetto H. (2008). Development of a HPLC method for the determination of antichagasic phenylethenylbenzofuroxans and its major synthetic secondary products in the chemical production processes. J Pharmaceut Biomed Anal 47:88–94.
   PubMed Web of Science ®Google Scholar
• Ghosh PB, Whitehouse MW. (1968). Potential antileukemic and immunosuppressive drugs. Preparation and in vitro pharmacological activity of some 2,1,3-benzoxadiazoles (benzofurazans) and their N-oxides (benzofuroxans). J Med Chem 11:305–311.
   PubMed Web of Science ®Google Scholar
• Grosa G, Galli U, Rolando B, Fruttero R, Gervasio G, Gasco A. (2004). Identification of 2,3-diaminophenazine and of o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan. Xenobiotica 34:345–352.
   PubMed Web of Science ®Google Scholar
• Heberling S, Girreser U, Wolf S, Clement B. (2006). Oxygen-insensitive enzymatic reduction of oximes to imines. Biochem Pharmacol 71:354–365.
   PubMedGoogle Scholar
• Hernández P, Merlino A, Gerpe A, Porcal W, Piro OE, González M, Cerecetto H. (2006). One-pot synthesis of benzyltriphenylphosphonium acetates from the corresponding activated benzyl alcohols. Arkivoc xi:128–136.
   Web of Science ®Google Scholar
• Hudson L, Grover F, Gutteridge WE, Klein RA, Peters W, Neal RA, Miles MA, Scott MT, Nourish R, Ager BP. (1983). Suggested guidelines for work with live Trypanosoma cruzi. Trans R Soc Trop Med Hyg 77:416–419.
   PubMedGoogle Scholar
• Marini S, Longo V, Mazzaccaro A, Gervase PG. (1998). Xenobiotic-metabolizing enzymes in pig nasal and hepatic tissues. Xenobiotica 28:923–935.
   PubMed Web of Science ®Google Scholar
• Medana C, Visentin S, Grosa G, Fruttero R, Gasco A. (2001). Nitroanilines are the reduction products of benzofuroxan system by oxyhemoglobin (HbO22+). Il Farmaco 56:799–802.
   PubMedGoogle Scholar
• Meyer RP, Podvinec M, Meyer UA. (2002). Cytochrome P450 CYP1A1 accumulates in the cytosol of kidney and brain and is activated by heme. Mol Pharmacol 62:1061–1067.
   PubMed Web of Science ®Google Scholar
• Morton DB, Griffiths PHM. (1985). Guidelines on the recognition of pain, distress and discomfort in experimental animal and a hypothesis for assessment. Vet Record 116:431–436.
   PubMed Web of Science ®Google Scholar
• Nisimoto Y, Otsuka-Murakami H, Iwata S, Isogai Y, Iizuka T. (1993). Characterization of superoxide dismutase-insensitive cytochrome c reductase activity in HL-60 cytosol as NADPH-cytochrome P450 reductase. Archiv Biochem Biophys 302:315–321.
   PubMedGoogle Scholar
• Olea-Azar C, Rigol C, Mendizábal F, Briones R, Cerecetto H, Di Maio R, González M, Porcal W, Risso M.2003a. Electrochemical and microsomal production of free radicals from 1,2,5-oxadiazole N-oxide as potential antiprotozoal drugs. Spectrochimica Acta A Mol Biomol Spectro 59:69–74.
   PubMedGoogle Scholar
• Olea-Azar C, Rigol C, Mendizábal F, Cerecetto H, Di Maio R, González M, Porcal W, Morello A, Repetto Y, Maya JD. (2005). Novel benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as antichagasic agents: Chemical and biological studies. Lett Drug Design Disc 2:294–301.
   Google Scholar
• Olea-Azar C, Rigol C, Opazo L, Morello A, Maya JD, Repetto Y, Aguirre G, Cerecetto H, Di Maio R, González M, Porcal W.2003b. ESR and spin trapping studies of two new potential antitrypanosomal drugs. J Chilean Chem Soc 48:77–79.
   Google Scholar
• Porcal W, Hernández P, Aguirre G, Boiani L, Boiani M, Merlino A, Ferreira A, Di Maio R, Castro A, González M, Cerecetto H. (2007). Second generation of 5-ethenylbenzofuroxan derivatives as inhibitors of Trypanosoma cruzi growth: Synthesis, biological evaluation and structure activity relationships. Bioorg Med Chem 15:2768–2781.
   PubMedGoogle Scholar
• Porcal W, Merlino A, Boiani M, Gerpe A, González M, Cerecetto H. (2008). Arylethenylbenzofuroxan derivatives as drugs for Chagas disease: multigram batch synthesis using a Wittig–Boden process. Organ Proc Res Devel 12:156–162.
   Google Scholar
• Straube E, Völkel W, Bringmann G, Dekant W. (2005). Reaction of nitroso derivatives of dinitropyrenes with sulfhydryl groups of peptides and hemoglobin in vitro and in rats. Xenobiotica 35:1147–1164.
   PubMed Web of Science ®Google Scholar
• Testa B, Soine W. (2003). Principles of drug metabolism. In: Abraham DJ, editor. Burger’s medicinal chemistry and drug discovery. 6th ed. Hoboken: Wiley-Interscience. Vol. 2. p. 431–498.
   Google Scholar
• Tracy JW, Vande Waa EA. (1995). Xenobiotic metabolism. In: Marr JJ, Müller M, editors. Biochemistry and molecular biology of parasites. London: Academic Press. p. 161–175.
   Google Scholar
• Yawetz A, Agosin M. (1981). Purification of the glutathione S-transferase of Trypanosoma cruzi. Comparat Biochem Phys B Biochem Mol Biol 68B:237–243.
   Google Scholar
• Zhu H, Qiu H, Yoon H-WP, Huang S, Bunn HF. (1999). Identification of a cytochrome b-type NAD(P)H oxidoreductase ubiquitously expressed in human cells. Proc Natl Acad Sci USA 96:14742–14747.
   PubMed Web of Science ®Google Scholar